drugset / Trial / NCT04976322
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate long-term safety and tolerability of dapirolizumab pegol treatment.
Timeline
- Start
- 2021-07-27
- Primary completion
- 2030-08-07
- Completion
- 2030-08-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapirolizumab pegol | Monoclonal antibody | — | — |